Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Cardiovascular adverse events in patients with cancer treated with chimeric antigen receptor (CAR) T-cell therapy: A meta-analysis of both controlled and single-arm clinical trials.

View Full Paper
Ask AI
Bookmark
Share

Authors

PMPhyo Thazin MyintUniversity of MissouriMKMonika KulasekaranUniversity of MissouriMYMuhammad YasirBacha Khan University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Myint et al. (2024) studied this question.

synapsesocial.com/papers/68e6706cb6db6435875fb328https://doi.org/10.1200/jco.2024.42.16_suppl.e19006
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cardiovascular effects associated with chimeric antigen receptor T cell therapy in cancer patients: A meta-analysis2022 · 24 citations
  2. 2Association of cardiotoxicity with chimeric antigen receptor T-cell (CAR-T) therapy: A systematic review.2026
  3. 3Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)2019 · 361 citations
  4. 4An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective Study2021 · 43 citations
  5. 5Cardiotoxicity of chimeric antigen receptor T-cell therapy: narrative review2026